Preorders for the iPhone 15 have begun, and here's a sign they've been 'solid'

Zynerba Pharmaceuticals Inc

Change company Symbol lookup

Select an option...

ZYNE Zynerba Pharmaceuticals Inc

PDO PIMCO Dynamic Income Opportunities Fund

BOCT Innovator U.S. Equity Buffer ETF™ October

BAC Bank of America Corp

YARIY Yara International ASA

XOM Exxon Mobil Corp

XLF Financial Select Sector SPDR® Fund

XFLT XAI Octagon Floating Rate & Alternative Income Term Trust

WPC WP Carey Inc

WMT WALMART STORES INC

Health Care : Pharmaceuticals | Small Cap Value

Company profile

Zynerba Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders. The Company is engaged in improving the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome (FXS), and chromosome 22q11.2 deletion syndrome (22q). It is focused on using cannabinoids for treating behavioral symptoms of FXS and 22q. It is developing Zygel (ZYN002), a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of tetrahydrocannabinol (THC). It uses a patent protected formulation containing ethanol and propylene glycol as solubilizing agents and Transcutol HP as a permeation enhancer. Zygel is an investigational drug product in development for the potential treatment of behavioral symptoms associated with FXS, 22q, and autism spectrum disorder (ASD).

Preorders for the iPhone 15 have begun, and here's a sign they've been 'solid'

8:57 am ET September 18, 2023 (MarketWatch) Print

By Emily Bary

Evercore is encouraged by iPhone delivery windows on Apple's online store

Wall Street analysts can no longer look at lines outside Apple Stores to get a gauge of iPhone demand, but Evercore ISI's Amit Daryanani still has a sense that preorders for the newest iPhone have been "solid" in their first few hours since going live.

He looked at delivery times online, and noted that "lead times got elevated rather quickly across the countries we track for the Pro and Pro Max models."

iPhone 15 preorders:Here are the deals from AT&T, T-Mobile and Verizon

When looking at SIM-free iPhones on Apple's (AAPL) website, he saw U.S. delivery estimates of seven days for the iPhone 15 Pro and 35 days for the iPhone 15 Pro Max, Apple's most expensive model. In China, delivery estimates were for 18 days and 32 days, respectively, across those devices.

"The lower-end models (15 Plus and 15 base) have significantly shorter delivery times across all regions (7 days), which points to a strong mix of higher priced iPhone 15 Pro and Pro Max models," he continued.

Apple's iPhone 15 vs. iPhone 13: Is the upgrade worth it?

Admittedly, online wait times aren't a perfect signal of interest in the new phones, which Apple announced earlier this week. Longer wait times could be a sign of high demand for the phones, or they could signal low supply.

This time around though, Daryanani is encouraged by "the variation in wait times," which "more likely suggests higher demand."

The data "continues to point to robust demand for the iPhone 15 Pro Max, although slightly weaker on Pro/Plus vs. last year, which could have a positive impact on mix somewhat offset by lower volumes," he continued.

See also: What's a better deal -- buying an iPhone 15 or investing $800 in Apple stock?

While preorders kicked off Friday morning, the iPhone doesn't officially become available until Sept. 22.

More from MarketWatch: How does the iPhone 15 compare to the latest Pixel and Galaxy devices?

-Emily Bary

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

September 18, 2023 08:57 ET (12:57 GMT)